Pfizer Emblaveo gets European Commission marketing nod for patients with multidrug-resistant infections and limited treatment options Ruchika Sharma26 April 2024 12:58 PM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for EMBLAVEO (aztreonam-avibactam) for...
Pfizer divests USD 3.5 billion stake in Haleon Ruchika Sharma21 March 2024 2:10 PM ISTSensodyne-marker Haleon has said that Pfizer, its top shareholder, divested approximately a $3.5 billion stake in the consumer healthcare firm,...
Pfizer gets European Commission marketing nod for Prevenar 20 to protect infants, children against Pneumococcal Disease Susmita Roy14 March 2024 1:29 PM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for the company's 20-valent...
RSV vaccine Abrysvo is protective through a second year: Pfizer Ruchika Sharma3 March 2024 12:00 PM ISTNew York: Pfizer has said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the...
Pfizer, NIPER Ahmedabad join hands to support healthcare innovation in India Ruchika Sharma28 Feb 2024 11:38 AM ISTNew Delhi: Pfizer has announced a collaboration with the National Institute of Pharmaceutical Education & Research (NIPER), Ahmedabad to...
Pfizer gets EU nod for ulcerative colitis drug Velsipity Ruchika Sharma20 Feb 2024 11:30 AM ISTThe approval, applicable in all 27 countries of the European Union, is based on studies from two late-stage trials that showed the drug was effective...
Pfizer agrees to pay USD 93 million to settle cholesterol drug Lipitor antitrust lawsuit Ruchika Sharma15 Feb 2024 2:16 PM ISTPfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy...
Pfizer, UT Southwestern collaborate to develop improved RNA Delivery Technologies Ruchika Sharma13 Feb 2024 4:30 PM ISTDallas: UT Southwestern Medical Center is partnering with Pfizer Inc. to develop RNA-enhanced delivery technologies for genetic medicine...
EMA validates Type II variation application for Padcev with Keytruda for first line treatment of advanced Bladder Cancer: Pfizer Ruchika Sharma28 Jan 2024 10:00 AM ISTTokyo: Astellas Pharma Inc. and Pfizer Inc. have announced that the European Medicines Agency (EMA) has validated for review a Type II...
Pfizer Gets CDSCO Panel Nod to Study Sisunatovir in Adults With Respiratory Syncytial Virus Infection Dr. Divya Colin18 Jan 2024 6:00 PM ISTNew Delhi: The drug major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Pfizer-Genmab Tivdak application accepted for priority review by USFDA for cervical cancer Ruchika Sharma10 Jan 2024 12:30 PM ISTNew York: Pfizer Inc. and Genmab A/S have announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental...
Pfizer gets European Commission nod for Talzenna, Xtandi combo for prostate cancer Ruchika Sharma9 Jan 2024 10:00 AM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has approved TALZENNA (talazoparib), an oral poly ADP-ribose polymerase...
